LRRK2 and Parkinson disease: Importantly for genetic subtypes, metabolomic studies have repeatedly reported lower circulating levels of caffeine and its metabolites (including paraxanthine) in PD patients and in carriers of pathogenic LRRK2 variants, supporting a link between impaired xanthine metabolism or altered exposure and disease susceptibility [7,14,45].